Related references
Note: Only part of the references are listed.Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice
Zakiyatul Faizah et al.
MOLECULES (2020)
Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU-MP-1, protects the heart against adverse effects during pressure overload
Efta Triastuti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Neratinib protects pancreatic beta cells in diabetes
Amin Ardestani et al.
NATURE COMMUNICATIONS (2019)
The Hippo Signaling Pathway in Pancreatic β-Cells: Functions and Regulations
Amin Ardestani et al.
ENDOCRINE REVIEWS (2018)
Hippo Signaling: Key Emerging Pathway in Cellular and Whole-Body Metabolism
Amin Ardestani et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice
Mingming Zhang et al.
DIABETOLOGIA (2016)
Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration
Fuqin Fan et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP
Qian Chen et al.
GENES & DEVELOPMENT (2015)
MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes
Amin Ardestani et al.
NATURE MEDICINE (2014)
Targeting the pancreatic β-cell to treat diabetes
Amedeo Vetere et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Loss of Pdk1-Foxo1 Signaling in Myeloid Cells Predisposes to Adipose Tissue Inflammation and Insulin Resistance
Yoshinaga Kawano et al.
DIABETES (2012)
Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice
Miki Nishio et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Protein kinases of the Hippo pathway: Regulation and substrates
Joseph Avruch et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Deletion of Irs2 causes reduced kidney size in mice: role for inhibition of GSK3β?
Rosemarie M. Carew et al.
BMC DEVELOPMENTAL BIOLOGY (2010)
The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
Nailing Zhang et al.
DEVELOPMENTAL CELL (2010)
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Hai Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
Kwang-Pyo Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
Dawang Zhou et al.
CANCER CELL (2009)
A Cell-Intrinsic Role for Mst1 in Regulating Thymocyte Egress
Yongli Dong et al.
JOURNAL OF IMMUNOLOGY (2009)
Blosignaling of mammalian Ste20-related kinases
Pin Ling et al.
CELLULAR SIGNALLING (2008)
The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia
Nadine S. Sauter et al.
ENDOCRINOLOGY (2008)
YAP1 increases organ size and expands undifferentiated progenitor cells
Fernando D. Camargo et al.
CURRENT BIOLOGY (2007)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
AE Butler et al.
DIABETES (2003)
β-cell death during progression to diabetes
D Mathis et al.
NATURE (2001)
Share Paper
